Groups | AUC | Sensitivity | Specificity |
---|---|---|---|
1Cancers(BC&RCC) vs controls | |||
 discovery group | 0.950(0.942–0.958) | 0.868(0.846–0.891) | 0.875(0.855–0.895) |
 10-fold cross-validation | 0.933(0.902–0.925) | 0.857(0.857–0.926) | 0.880(0.822–0.939) |
2BC vs RCC without hematuria | |||
 discovery group | 0.829(0.802–0.855) | 0.832(0.801–0.862) | 0.706(0.666–0.747) |
 10-fold cross-validation | 0.784(0.695–0.874) | 0.802(0.802–0.908) | 0.698(0.575–0.822) |
3BC vs RCC with hematuria | |||
 discovery group | 0.913(0.885–0.942) | 0.847(0.795–0.898) | 0.953(0.937–0.970) |
 10-fold cross-validation | 0.870(0.754–0.986) | 0.857(0.857–1.00) | 0.913(0.847–0.980) |